{"title":"GAO: DEA, FDA lack procedures guiding drug scheduling decisions","authors":"Gary Enos","doi":"10.1002/adaw.35064","DOIUrl":null,"url":null,"abstract":"<p>At a time when addiction field professionals and advocates await a decision on the possible rescheduling of marijuana, a report from Congress's Government Accountability Office (GAO) has uncovered gaps in the overall evaluations conducted by the federal agencies involved in all drug scheduling decision-making processes.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"38 38","pages":"1-6"},"PeriodicalIF":0.0000,"publicationDate":"2026-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alcoholism & Drug Abuse Weekly","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/adaw.35064","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
At a time when addiction field professionals and advocates await a decision on the possible rescheduling of marijuana, a report from Congress's Government Accountability Office (GAO) has uncovered gaps in the overall evaluations conducted by the federal agencies involved in all drug scheduling decision-making processes.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
